A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I
NCT06162338
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Gaucher Disease Type I
Interventions
BIOLOGICAL:
LY-M001 Injection
Sponsor
He Huang
Collaborators
[object Object]